JP2008546373A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008546373A5 JP2008546373A5 JP2008504018A JP2008504018A JP2008546373A5 JP 2008546373 A5 JP2008546373 A5 JP 2008546373A5 JP 2008504018 A JP2008504018 A JP 2008504018A JP 2008504018 A JP2008504018 A JP 2008504018A JP 2008546373 A5 JP2008546373 A5 JP 2008546373A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- glp
- polypeptide
- mimetibody
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2005097175 | 2005-03-28 | ||
| PCT/US2005/046884 WO2007081302A2 (en) | 2005-03-28 | 2005-12-22 | Human glp-1 mimetibodies, compositions, methods and uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008546373A JP2008546373A (ja) | 2008-12-25 |
| JP2008546373A5 true JP2008546373A5 (https=) | 2009-03-05 |
Family
ID=38256744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008504018A Pending JP2008546373A (ja) | 2005-03-28 | 2005-12-22 | ヒトｇｌｐ−１ミメティボディ、組成物、方法および用途 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1871811A4 (https=) |
| JP (1) | JP2008546373A (https=) |
| KR (1) | KR20080005378A (https=) |
| CN (1) | CN101389346A (https=) |
| AU (1) | AU2005339797A1 (https=) |
| BR (1) | BRPI0520168A2 (https=) |
| CA (1) | CA2603359A1 (https=) |
| CR (1) | CR9481A (https=) |
| IL (1) | IL186307A0 (https=) |
| MX (1) | MX2007011975A (https=) |
| NO (1) | NO20075272L (https=) |
| WO (1) | WO2007081302A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200843794A (en) | 2006-12-21 | 2008-11-16 | Centocor Inc | Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles |
| CN111574583B (zh) * | 2020-04-10 | 2021-06-25 | 上海海路生物技术有限公司 | 蛋白复性试剂及其应用 |
| CN120741086A (zh) * | 2024-07-26 | 2025-10-03 | 荣耀终端股份有限公司 | 模拟人体组织液及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6656728B1 (en) * | 1999-02-08 | 2003-12-02 | Chiron Corporation | Fibroblast growth factor receptor-immunoglobulin fusion |
| BR0116024A (pt) * | 2000-12-07 | 2005-12-13 | Lilly Co Eli | Proteìna de fusão heteróloga e uso da mesma |
| AU2003280130B2 (en) * | 2002-06-28 | 2009-06-11 | Centocor, Inc. | Mammalian CH1 deleted mimetibodies, compositions, methods and uses |
| JP2005536992A (ja) * | 2002-06-28 | 2005-12-08 | セントカー・インコーポレーテツド | 哺乳動物のｅｐｏ模倣ｃｈ１欠失ミメティボディ、組成物、方法および使用 |
| EP1644416A4 (en) * | 2003-06-30 | 2007-08-29 | Centocor Inc | ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| JP2008537873A (ja) * | 2004-03-31 | 2008-10-02 | セントカー・インコーポレーテツド | ヒトｇｌｐ−１ミメティボディ、組成物、方法および用途 |
-
2005
- 2005-12-22 JP JP2008504018A patent/JP2008546373A/ja active Pending
- 2005-12-22 WO PCT/US2005/046884 patent/WO2007081302A2/en not_active Ceased
- 2005-12-22 MX MX2007011975A patent/MX2007011975A/es not_active Application Discontinuation
- 2005-12-22 CA CA002603359A patent/CA2603359A1/en not_active Abandoned
- 2005-12-22 KR KR1020077024874A patent/KR20080005378A/ko not_active Withdrawn
- 2005-12-22 EP EP05858723A patent/EP1871811A4/en not_active Withdrawn
- 2005-12-22 AU AU2005339797A patent/AU2005339797A1/en not_active Abandoned
- 2005-12-22 BR BRPI0520168-3A patent/BRPI0520168A2/pt not_active Application Discontinuation
- 2005-12-22 CN CNA200580049931XA patent/CN101389346A/zh active Pending
-
2007
- 2007-09-25 IL IL186307A patent/IL186307A0/en unknown
- 2007-10-15 NO NO20075272A patent/NO20075272L/no not_active Application Discontinuation
- 2007-10-29 CR CR9481A patent/CR9481A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008525477A5 (https=) | ||
| JP2007508011A5 (https=) | ||
| JP2005512522A5 (https=) | ||
| CN107207618B (zh) | 包含glp和免疫球蛋白杂合fc的融合多肽及其用途 | |
| KR100989647B1 (ko) | 식습관의 변화 | |
| US9944687B2 (en) | Compounds and their effects on feeding behaviour | |
| EP1729792B1 (en) | Y4 selective receptor agonist for therapeutic interventions | |
| ME02185B (me) | Anti-il-6 antitela, preparati, postupci pripreme i upotrebe | |
| KR20070004078A (ko) | 인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도 | |
| TR201802689T4 (tr) | Glukagon benzeri peptit-2 (glp-2) analogları. | |
| US20180280480A1 (en) | Compositions and peptides having dual glp-1r and glp-2r agonist activity | |
| JP2010514699A (ja) | インスリン感受性および脂質プロファイルを改善するための長時間作用型ｇｌｐ−１受容体アゴニストの使用 | |
| TW201934571A (zh) | Ｆｇｆ２１變體、融合蛋白及其應用 | |
| JP2020533302A (ja) | 肥満の治療において使用するためのｍｉｃ−１およびｇｌｐ−１ | |
| TW202028228A (zh) | 人類澱粉素(amylin)類似物多肽及使用方法 | |
| ES2660739T3 (es) | Tratamiento de cáncer de pulmón usando el inhibidor SIS3 de Smad3 | |
| TW202237628A (zh) | 長效性類升糖素多肽-1(glp-1)受體促效劑及其使用方法 | |
| CN115485292A (zh) | 新的双特异性蛋白及其用途 | |
| JP2023522081A (ja) | 長時間作用型ペプチドチロシンチロシン（ｐｙｙ）類似体及び使用方法 | |
| JP2008546373A5 (https=) | ||
| JP2021505656A (ja) | グルカゴン様ペプチド | |
| JP2009526750A5 (https=) | ||
| KR20090077935A (ko) | 내당능 장애 관련 증상을 예방하거나 치료하기 위한 인간 ｅｐｏ 수용체 작용제, 조성물, 방법 및 용도 | |
| CN104918954A (zh) | N-末端电荷发生变化的胰岛素分泌肽衍生物 | |
| WO2025098335A1 (zh) | 一类多肽在制备治疗肥胖及其合并症的药物、食品或保健品中的用途 |